Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development-Reference-Cited by-同舟云学术

Discovery of RG7112: A Small-Molecule MDM2 Inhibitor in Clinical Development

Published:2013-04-04 Issue:5 Volume:4 Page:466-469
ISSN:1948-5875
Container-title:ACS Medicinal Chemistry Letters
language:en
Short-container-title:ACS Med. Chem. Lett.

Author:

Vu Binh¹,Wovkulich Peter¹,Pizzolato Giacomo¹,Lovey Allen¹,Ding Qingjie¹,Jiang Nan¹,Liu Jin-Jun¹,Zhao Chunlin¹,Glenn Kelli¹,Wen Yang¹,Tovar Christian¹,Packman Kathryn¹,Vassilev Lyubomir¹,Graves Bradford¹

Affiliation:

1. Discovery Chemistry, ‡Discovery Oncology, §Discovery Technologies, ∥Non-Clinical Development, Roche Research Center, Hoffmann-La Roche, Inc., 340 Kingsland Street, Nutley, New Jersey 07110, United States

Publisher

American Chemical Society (ACS)

Subject

Organic Chemistry,Drug Discovery,Biochemistry

Link

https://pubs.acs.org/doi/pdf/10.1021/ml4000657

Reference25 articles.

1. The p53 pathway: positive and negative feedback loops

2. Surfing the p53 network

3. p53, the Cellular Gatekeeper for Growth and Division

4. p53 and Human Cancer: The First Ten Thousand Mutations

5. Functions of the MDM2 oncoprotein

Cited by 295 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discovery of therapeutic targets in cancer using chromatin accessibility and transcriptomic data;Cell Systems;2024-09

2. Ursodeoxycholic acid inhibits the uptake of cystine through SLC7A11 and impairs de novo synthesis of glutathione;Journal of Pharmaceutical Analysis;2024-08

3. Insights into the Interaction Mechanisms of Peptide and Non-Peptide Inhibitors with MDM2 Using Gaussian-Accelerated Molecular Dynamics Simulations and Deep Learning;Molecules;2024-07-18

4. Enzymatic Desymmetrisation of Prochiral meso-1,2-Disubstituted-1,2-Diaminoethane for the Synthesis of Key Enantioenriched (−)-Nutlin-3 Precursor;Molecules;2024-07-10

5. Targeting Hdm2 and Hdm4 in Anticancer Drug Discovery: Implications for Checkpoint Inhibitor Immunotherapy;Cells;2024-06-29